Near-optimal glycemic control in Chilean women with pregestational type-2 diabetes: Persistent macrosomia relates to maternal pre-pregnancy overweight

Diabetes Research and Clinical Practice

Volumn 85, Issue 1, 2009, Pages 53-60

  Olmos, Pablo R ^a   Araya Del Pino, Andrea P ^a   González Carvello, Cristián A ^a   Laso Ulloa, Pablo ^a   Hodgson, María I ^a   Irribarra, Verónica ^a   Borzone, Gisella R ^a   Belmar, Cristián ^a   Poblete, Andrés ^a   Berríos, Cecilia ^a   Becker, Jorge ^a   Zajer Amar, Claudia M ^a   Manzur, Alejandro ^a   Bozinovic, Milan ^a   Miranda, Ramón J ^a   Diez, Alberto ^a   Vidal, Hernán ^a   Ramírez Armijo, Renato ^a   Olmos, Roberto I ^a   Tabilo, Cristián ^a   Ahuad, Jessica ^a   more..

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Diabetes; Macrosomia; Overweight; Pregestational

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSUMAN N; INSUMAN R; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MAJOR CLINICAL STUDY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PREGNANCY DIABETES MELLITUS;

BIRTH WEIGHT; BODY MASS INDEX; CESAREAN SECTION; CHILE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FETAL DEATH; GESTATIONAL AGE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT, NEWBORN; OVERWEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS;

EID: 67349151310     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.04.015     Document Type: Article

References (33)

1. Lapolla A., Dalfrà M.G., and Fedele D. Pregnancy complicated by type 2 diabetes: an emerging problem. Diab. Res. Clin. Pract. 80 (2008) 2-7
2. Tilton Z., Hodgson M.I., Donoso E., Arteaga A., and Rosso P. Complications and outcome of pregnancy in obese women. Nutrition 5 2 (1989) 95-99
3. Ricart W., López J., Mozas J., Pericot A., Sancho M.A., González N., et al. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 48 (2005) 1736-1742
4. Ehremberg H.M., Mercer B.M., and Catalano P.M. The influence of obesity and diabetes on the prevalence of macrosomia. Am. J. Obstet. Gynecol. 191 (2004) 964-968
5. Wong S.F., Lee-Tannock A., Amaraddio D., Chan F.Y., and McIntyre H.D. Fetal growth patterns in fetuses of women with pregestational diabetes mellitus. Ultrasound Obstet. Gynecol. 28 (2006) 934-938
6. Appendix 4, World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia, Report of a WHO/IDF Consultation, World Health Organization, 1999, p. 38.
7. Diagnosis and Classification of Diabetes Mellitus, in: American Diabetes Association, Clinical Practice Recommendations 2009, Diab. Care 32 (Suppl. 1) (2009) S62-S67.
8. Malecki M.T., and Skupien J. Problems in the differential diagnosis of diabetes types. Pol. Arch. Med. Wewn. 118 7-8 (2008) 435-440
9. M.T. Malecki, T. Klupa, Type 2 diabetes mellitus: from genes to disease, Pharmacol. Rep. 57 (Suppl.) (2005) 20-32.
10. Howorka K. Functional Insulin Treatment: Principles Teaching Approach and Practice (1996), Springer-Verlag, Berlin/Heidelberg, Germany
11. Bastias M.J., Toro L., and Olmos P. Intensified insulin therapy plus antineuritic medication is more effective than antineuritics alone in painful diabetic neuropathy. Rev. Med. Chil. 134 12 (2006) 1507-1515
12. Bernasko J. Intensive insulin therapy in pregnancy: strategies for successful implementation in pregestational diabetes mellitus. J. Matern. Fetal Neonatal Med. 20 2 (2007) 125-132
13. Jovanovic L. Advances in diabetes for the millennium: diabetes in women. Medsc. Gen. Med. 6 3 Suppl. (2004) 1-13
14. González R., Gómez R., Castro R., Inen J.K., Merino P., Etchegaray A., et al. A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000. Rev. Med. Chil. 132 (2004) 1155-1165
15. Mardones F., and Rosso P. A weight gain chart for pregnant women designed in Chile. Matern. Child Nutr. 1 (2005) 77-90
16. D. Machin, M.J. Campbell, P.M. Fayers, A.P.Y. Pinol, Comparing independent groups for binary, ordered categorical and continuous data, in: Sample Size Tables for Clinical Studies, 2nd ed., Blackwell Science, Oxford, UK, 1997, pp. 16-68.
17. R.R. Sokal, F.J. Rohlf, Finding the sample size n required for a test, in: Biometry. The Principles and Practice of Statistics in Biological Research, 2nd ed., W.H. Freeman and Company, New York, USA, 1981, pp. 262-270.
18. S.G. Gabbe, J.R. Niebyl, J.L. Simpson, Obstetrics: Normal and Problem Pregnancies, 4th ed., Churchill Livingstone, New York, USA, 2002.
19. National Population Health Survey (ENS 2003), Ministry of Health of Chile, Santiago, 2004. Available from: http://epi.minsal.cl/epi/html/invest/ENS/InformeFinalENS.pdf (accessed on February 6, 2009).
20. Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet. Gyn. Scand. 87 (2008) 134-145
21. Zhang X., Decker A., Platt R.W., and Kramer M.S. How big is too big? The perinatal consequences of macrosomia. Am. J. Obstet. Gynecol. 198 (2008) 517.e1-517.e6
22. Merzouk H., and Khan N.A. Implications of lipids in macrosomia of diabetic pregnancy; can n-3 polynsaturated fatty acids exert beneficial effects?. Clin. Sci. (Lond.) 105 (2003) 519-529
23. Jolly M.C., Sebire N.J., Bharris J.P., Regan L., and Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350 311 pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 111 (2003) 9-14
24. Evers I.M., DeValk H.W., Mol B.W.J., TerBraak E.W.M.T., and Visser G.H.A. Macrosomia despite good glycemic control in type I diabetic pregnancy; results of a nationwide study in the Netherlands. Diabetologia 45 (2002) 1484-1489
25. Jansson N., Greenwood S.L., Johansson B.R., Powell T.L., and Jansson T. Leptin stimulates the activity of the system A aminoacid transporter in human placental villous fragments. J. Clin. Endocrinol. Metab. 88 (2003) 1205-1211
26. Dubey L., and Hesong Z. Role of leptin in atherogenesis. Exp. Clin. Cardiol. 11 4 (2006) 269-275
27. Verhaeghe J., Pintiaux A., Van Herck E., Hennen G., Foidart J.-M., and Igout A. Placental GH, IGF-1, and Leptin during glucose challenge test in pregnanto women: relation with maternal body weight, glucose tolerance, and birth weight. J. Clin. Endocrinol. Metab. 87 (2002) 2875-2882
28. Herrera E., Amusquivar E., López-Soldado I., and Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm. Res. 65 Suppl. 3 (2006) 59-64
29. Magnusson-Olsson A.L., Hamark B., Ericsson A., Wennergren M., Jansson T., and Powell T.L. Gestational and hormonal regulation of human placental lipoprotein lipase. J. Lip. Res. 47 (2006) 2551-2561
30. Schaefer-Graf U.M., Graf K., Kulbancka I., Jjos S.L., Dudenhausen J., Vetter K., et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diab. Care 31 9 (2008) 1858-1863
31. Montelongo A., Lasunción M., Pallardo L., and Herrera E. Longitudinal study of plasma lipoproteins during pregnancy in normal and diabetic women. Diabetes 41 (1992) 1651-1659
32. Merzouk H., Bouchenak M., Loukidi B., Madani S., Prost J., and Belleville J. Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition. J. Clin. Pathol. 53 (2000) 917-923
33. Lain K.Y., and Catalano P.M. Metabolic changes in pregnancy. Clin. Obstet. Gynecol. 50 4 (2007) 938-948